INR 24.67
(0.04%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 70.17 Million | 235.09 Million | 26.72 Million | - | 25.33 Million | 201.33 Million |
Cost of Revenue | 67.07 Million | 231.62 Million | 23.36 Million | - | 25.45 Million | 196.76 Million |
Gross Profit | 3.1 Million | 3.46 Million | 3.36 Million | - | -122 Thousand | 4.57 Million |
Operating Expenses | 3.05 Million | 3.44 Million | 3.16 Million | 3.37 Million | 3.16 Million | 5.46 Million |
Selling, General and Administrative Expenses | 3.04 Million | 3.14 Million | 3.16 Million | 3.37 Million | 3.16 Million | 5.42 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 7000.00 | -301 Thousand | -7000.00 | -2000.00 | - | -33 Thousand |
Cost and Expenses | 70.12 Million | 235.07 Million | 26.53 Million | 3.37 Million | 28.61 Million | 202.22 Million |
Operating Income | 53 Thousand | 16 Thousand | 197 Thousand | -3.37 Million | -3.28 Million | -890 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 28 Thousand | 25 Thousand | 57 Thousand | 50 Thousand | 35 Thousand | 2.58 Million |
Earnings before Tax | 53 Thousand | 16 Thousand | 197 Thousand | 123 Thousand | -3.28 Million | -8.95 Million |
Net Income | 25 Thousand | -9000.00 | 140 Thousand | 73 Thousand | -3.32 Million | -11.54 Million |
Earnings Per Share Basic | 0.01 | -0.00 | 0.04 | 0.02 | -1.01 | -3.51 |
Earnings Per Share Diluted | 0.01 | -0.00 | 0.04 | 0.02 | -1.01 | -3.51 |
Weighted Average Shares Outstanding | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million |
Weighted Average Shares Outstanding (Diluted) | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million |
Gross Margin | 0.04 | 0.01 | 0.13 | - | -0.00 | 0.02 |
EBIT Margin | 0.00 | 0.00 | 0.01 | - | -0.13 | -0.00 |
Profit Margin | 0.00 | -0.00 | 0.01 | - | -0.13 | -0.06 |
EBITDA | 53 Thousand | 16 Thousand | 197 Thousand | 123 Thousand | -3.28 Million | -8.65 Million |
Earnings Before Tax Margin | 0.00 | 0.00 | 0.01 | - | -0.13 | -0.00 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 43.26 Million | 70.17 Million | 70.17 Million | - | - | - |
Cost of Revenue | 43.1 Million | 67.07 Million | 66.01 Million | - | - | - |
Gross Profit | 157 Thousand | 3.1 Million | 4.16 Million | - | - | - |
Operating Expenses | 417 Thousand | 3.05 Million | 352 Thousand | 816 Thousand | 807 Thousand | 2.12 Million |
Selling, General and Administrative Expenses | 417 Thousand | - | 352 Thousand | 816 Thousand | 807 Thousand | 2.12 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | -7000.00 | - | - | - | - |
Cost and Expenses | 43.52 Million | 70.12 Million | 66.36 Million | 816 Thousand | 807 Thousand | 2.12 Million |
Operating Income | -260 Thousand | 53 Thousand | 3.81 Million | -816 Thousand | -807 Thousand | -2.12 Million |
Interest Expense | - | - | 2000.00 | - | - | - |
Income Tax Expense | - | 28 Thousand | 28 Thousand | 39.58 Thousand | -122.08 Thousand | -41.58 Thousand |
Earnings before Tax | -228 Thousand | 53 Thousand | 3.81 Million | -816 Thousand | -807 Thousand | -2.13 Million |
Net Income | -228 Thousand | 25 Thousand | 3.78 Million | -816 Thousand | -807 Thousand | -2.13 Million |
Earnings Per Share Basic | -0.07 | - | 1.15 | -0.25 | -0.25 | -0.65 |
Earnings Per Share Diluted | -0.07 | - | 1.15 | -0.25 | -0.25 | -0.65 |
Weighted Average Shares Outstanding | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million |
Weighted Average Shares Outstanding (Diluted) | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million | 3.28 Million |
Gross Margin | 0.00 | 0.04 | 0.06 | - | - | - |
EBIT Margin | -0.01 | - | 0.05 | - | - | - |
Profit Margin | -0.01 | 0.00 | 0.05 | - | - | - |
EBITDA | -260 Thousand | - | 3.81 Million | -816 Thousand | -807 Thousand | -2.12 Million |
Earnings Before Tax Margin | -0.01 | 0.00 | 0.05 | - | - | - |
ML-WT
EGF
TOEN
004430
1V3
EMBR3